Epidermolysis Bullosa: Bridging Disease Complexity with Therapeutic Innovation
Time: 3:45 pm
day: Day One
Details:
- Uncover the diverse genetic landscape of EB and how understanding molecular mechanisms can inform therapeutic strategies and target selection
- Navigate the unique challenges of rare disease patient recruitment, trial design, and addressing disease heterogeneity
- Examine emerging preclinical developments for EB and key considerations for translating these innovations to the clinic
